These ASX 300 shares could rise 20% to 65%

Big returns could be on the cards for these shares according to analysts.

| More on:
A young man wearing a black and white striped t-shirt looks surprised.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Investors who are looking to supercharge their investment returns might want to check out the ASX 300 shares that are listed below.

That is because some of Australia's leading analysts think these shares are severely undervalued by the market and are tipping very big returns from them over the next 12 months.

Here's what analysts are predicting for these ASX 300 shares:

Inghams Group Ltd (ASX: ING)

Analysts at Morgans think that this poultry producer "remains undervalued trading on a low PE multiple, especially for what is a market leader, with a vertically integrated operating model and assets that are difficult and costly to replicate."

In addition, the broker highlights that Inghams is well-positioned to benefit from poultry being "the affordable, healthy, sustainable and growth protein."

Morgans currently has an add rating and a $4.40 price target on the ASX 300 share. Based on the current Inghams share price of $3.54, this implies a potential upside of 24% for investors over the next 12 months.

Lynas Rare Earths Ltd (ASX: LYC)

Goldman Sachs thinks investors should be snapping up this rare earths producer's shares while they are down in the dumps. The broker feels that its shares are undervalued "trading at ~0.8x NAV." Especially given its expectation for the "NdPr market [to be] balanced over medium term but deficits over long run."

Goldman Sachs currently has the company on its coveted Asia Pacific conviction list with a buy rating and a $7.40 price target. Based on its current share price of $6.17, this suggests that the ASX 300 share could rise by 20% from current levels.

Tyro Payments Ltd (ASX: TYR)

This payments company's shares have lost over 40% of their value since this time last year. While this is disappointing, the team at Morgans believes that this has created a compelling buying opportunity for investors.

Its analysts note that "TYR sold off heavily in 2023 affected by the broad pull back in technology stocks and overall concerns regarding its earnings trajectory."

They believe that "FY24 will show significantly improved business momentum, importantly driven by a much greater focus on lifting overall profitability." Despite this, the broker points out that "TYR still trades at a significant discount to valuation."

Morgans currently has an add rating and a $1.50 price target on its shares. Based on its current share price of 90.5 cents, this implies a potential upside of 65% for investors over the next 12 months.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group and Tyro Payments. The Motley Fool Australia has recommended Tyro Payments. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A man holds his head in his hands, despairing at the bad result he's reading on his computer.
Broker Notes

Why these 4 ASX 200 shares just got downgraded by top brokers

Leading brokers have downgraded their outlooks for these ASX 200 shares. But why?

Read more »

Investor sitting in front of multiple screens watching share prices
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A young man wearing a black and white striped t-shirt looks surprised.
Broker Notes

Why this beaten-down ASX 200 stock can jump 24%

Goldman Sachs thinks this sold off stock could generate big returns for investors.

Read more »

Man with a sleep apnoea mask on whilst sleeping.
Broker Notes

ResMed shares higher as company 'turns the GLP threat into an opportunity': Fundie

ResMed is having a great run in 2024 with the share price up 29% already.

Read more »

Two miners standing together.
Materials Shares

Buy one, sell the other: Goldman's verdict on these 2 ASX lithium shares

The broker says lithium prices will not bottom until 2025. Here's what you should do in the meantime.

Read more »

Woman checking out new iPads.
Retail Shares

Dump 'em! Top broker says sell these 3 ASX retail shares

This comes amid high interest rates, weak retail sales, and persistently negative consumer sentiment.

Read more »

A young woman sits with her hand to her chin staring off to the side thinking about her investments.
Broker Notes

Down 16% in 6 weeks: Is this ASX 200 share a bargain buy?

Bell Potter has given its verdict on this beaten down stock.

Read more »

Three people in a corporate office pour over a tablet, ready to invest.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to snap up these shares.

Read more »